Related Experiment Videos
Pharmacology of therapeutic oligonucleotides
1Department of Pharmacology and Toxicology University of Alabama at Birmingham 35294, USA.
Antisense & Nucleic Acid Drug Development
|June 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantitative Contribution of rs75017182 to Dihydropyrimidine Dehydrogenase mRNA Splicing and Enzyme Activity.
Clinical pharmacology and therapeutics·2017
Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population.
Clinical pharmacology and therapeutics·2016
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
Clinical pharmacology and therapeutics·2013
A DPYD variant (Y186C) in individuals of african ancestry is associated with reduced DPD enzyme activity.
Clinical pharmacology and therapeutics·2013
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo.
Antisense & nucleic acid drug development·2003
Safety of CpG oligodeoxynucleotides in veterinary species.
Antisense & nucleic acid drug development·2003
Coupling of RNAi-mediated target downregulation with gene replacement.
Antisense & nucleic acid drug development·2003
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
Antisense & nucleic acid drug development·2003
Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
Antisense & nucleic acid drug development·2003
Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
Antisense & nucleic acid drug development·2003
Bioactive Constituents of Piper crocatum Ruiz & Pav. and Piper betle Linn. as Antifungal and Antibiofilm Agents Against Candida albicans.
Drug design, development and therapy·2026
Divergent Syntheses of Euphorbia Diterpenoids: A Relay Rearrangement Strategy Triggered by Pyridinium Ring Contraction.
Journal of the American Chemical Society·2026
A Repurposed S-Adenosyl-l-Methionine Synthetase Mediates Cytidyl-Cyclitol Natural Product Assembly.
Journal of the American Chemical Society·2026
Small-Molecule-Directed RNA Modification via Proximity-Driven Catalysis.
Journal of the American Chemical Society·2026